Ascelia Pharma Ab Is A Biotechnology Company Based In Malma Swedenfocused On Developing Treatments For Rarecancer Conditionsfounded In 1999Thecompany Aims To Improveoutcomes For Patients With Complex Cancer Diagnoses Through Innovativetherapeutic And Diagnostic Solutionswith A Small Team Of Approximately 11Ae1 Employeesascelia Pharma Operates In Thehealthcaresectorprioritizing Orphan Oncology Drug Development Thecompany Has Two Main Products In Its Pipelineorviglanceis A Non Gadolinium Contrast Agent Designed For Liver Mri Scansspecifically For Patients With Impaired Kidney Functionit Has Completed Phaseii Trials And Is Currently In Phaseiii Developmentoncoral Is An Oral Formulation Of Irinotecanaimed At Enhancing Tolerability For Patients Undergoing Chemotherapy For Gastric Cancerand Is In Phaseii Developmentascelia Pharma Targets Nichemarkets With Limited Treatment Optionsemphasizing Regulatory Pathways For Orphan Drug Designation
No conferences found for this company.
| Company Name | Cmc Contrast Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
